Products
Online Inquiry
Miltefosine
Cat. No.:
0225LY-1080
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Miltefosine is recognized as the only effective oral treatment for both cutaneous and visceral leishmaniasis and is currently undergoing various international clinical trials.
Synonym:
HePC; Hexadecyl phosphocholine; 58066-85-6; Hexadecylphosphocholine; Miltex; Impavido; HDPC; Hexadecylphosphorylcholine; Miltefosina; Miltefosinum; n-Hexadecylphosphorylcholine; n-hexadecylphosphocholine; Miltefos; 1-Hexadecylphosphorylcholine; Hexadecyl 2-(trimethylazaniumyl)ethyl phosphate; Miltefosin; Hexadecyl 2-(trimethylammonio)ethyl phosphate; Miltefosin C; Fos-choline 16; Hexadecyl (2-(trimethylAmmonio)ethyl) phosphate; Monohexadecylphosphocholine; Hexadecyl phosphocholine; 2-(((Hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethylethanaminium hydroxide, inner salt; Choline phosphate, hexadecyl ester, hydroxide, inner salt
CAS No.:
58066-85-6
Compound CID:
3599
Formula:
C21H46NO4P
Formula Weight:
407.57
Specification
Targets&IC50:
PKC: 7 μM
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Miltefosine can be used in parasitology research to examine its efficacy against Leishmania and its role in modulating cell membrane signaling.
Library Information
Target:
PKC; Akt; HIV protease
Receptor:
PKC; Akt; HIV protease
Pathways:
Microbiology/Virology; Chromatin/Epigenetic; Cytoskeletal signaling; PI3K/Akt/mTOR signaling; Proteases/Proteasome
Plate Number:
AOCL-14
Plate Location:
h6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
2mM Water
Water Max Solubility:
10 mM
ALogP:
3.722
HBA_Count:
2
HBD_Count:
0
Rotatable Bond:
20
